This Follow-up Extension Study is Aimed to Monitor the Long-term IOP-lowering Performance/Efficacy and Safety of the MINT® Procedure in Open Angle Glaucoma Eyes.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Sanoculis Ltd
Age
18–85
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
1. Male or female ≥ 18 years to ≤ 85 years old
2. Subject who underwent MINT, in continuation of the previous clinical investigation with the MINT® device (see: STUDY ID: MMS EEU-4), and surgery was performed not earlier than 30 months from enrollment
3. Subject is able and willing to attend all scheduled follow-up exams
4. Subject understands and signs the informed consent
You may not be if
1. Subject who was withdrawn from the previous studies (MMS EEU-4 and MMS EEU-7)
2. Any ocular surgery since the MINT® surgery in the study eye
3. Severe trauma in the study eye since the MINT® surgery in the study eye (except for uncomplicated cataract surgery or laser therapy)
4. Current participation in another investigational drug or device clinical trial or participation is such trial within the last 30 days before enrollment into the study
5. Pregnant or lactating women
Clareo Health | This Follow-up Extension Study is Aimed to Monitor the Long-term IOP-lowering Performance/Efficacy and Safety of the MINT® Procedure in Open Angle Glaucoma Eyes.
